Cite
HARVARD Citation
Chen, Y. et al. (2018). Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East‐Asian patients with type 2 diabetes in a multicentre, double‐blind, randomized, parallel‐arm, active comparator, phase III trial. Diabetes, obesity & metabolism. 20 (9), pp. 2121-2130. [Online].